Deep Infiltrating Endometriosis With or Without Bowel Involvement
Investigational drug(s) / intervention(s)
intraoperative ultrasound for the assessment of bowel deep infiltrating endometriosis
intraoperative ultrasound for the assessment of bowel deep infiltrating endometriosis: Women with posterior compartment deep infiltrating endometriosis with or without bowel involvement scheduled for surgical treatment at the Department of Obstetrics, Gynecology, and Reproductive Medicine of Dexeus University Hospital.
Study summary
This study investigates the use of intraoperative transvaginal (IOTVUS) and/or endorectal ultrasound (IOERUS) in the surgical treatment of bowel deep infiltrating endometriosis (DIE).
Eligibility
Sex
FEMALE
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Preoperative sonographic and/or MRI findings suggestive of bowel DIE (uterosacral ligaments, posterior vaginal wall, parametrium, retrocervical area, rectovaginal septum, rectum, and/or sigmoid colon).
* Scheduled for surgical treatment (laparoscopy or robot-assisted laparoscopy).
* Planned postoperative follow-up for at least 12 months.
* Written informed consent provided before surgery.
Exclusion Criteria:
* Planned surgery for diagnostic purposes only.
* Pregnancy at the time of enrollment.
* Poor understanding of Spanish or English.
Primary outcome measure(s)
Feasibility of intraoperative ultrasound — Day of surgery o The proportion of patients in whom intraoperative ultrasound techniques can successfully identify rectal or rectosigmoid junction deep infiltrating endometriosis nodules during surgery.
Accuracy of intraoperative ultrasound — Day of surgery o Agreement between intraoperative ultrasound findings and histopathological results regarding the depth of infiltration and size of bowel DIE nodules.
Trial sites (1)
Facility
City
Region
Status
Departamento de Ginecología Obstetricia y Reproducción. Hospital Universitari Dexeus
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.
